newsio aggregates and links to original sources. We do not own the original images or content. If you believe content infringes on intellectual property rights, contact us — it will be removed at first notice.

biotech / news / / GlobeNewswire

BioNTech has authorized a new share repurchase program.

BioNTech has authorized a new share repurchase program of up to $1.0 billion in ADSs.

KEY POINTS
COMPANIES
Read the full story on GlobeNewswire →
Share X LinkedIn

Summarized by Newsio from GlobeNewswire. How we summarize →